Trial Profile
Effect of deferasirox given twice daily in patients with beta-thalassemia major
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Apr 2015
Price :
$35
*
At a glance
- Drugs Deferasirox (Primary)
- Indications Beta-thalassaemia
- Focus Therapeutic Use
- 17 Apr 2015 New trial record